ADAM C DERBYSHIRE Insider Trading $SLXP SALIX PHARMACEUTICALS LTD
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ADAM C DERBYSHIRE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ADAM C DERBYSHIRE. ADAM C DERBYSHIRE is EVP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP) and Sr. VP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP).
ADAM C DERBYSHIRE in SALIX PHARMACEUTICALS LTD
Trading Symbol: SLXPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ADAM C DERBYSHIRE: EVP Finance/CFO, Sr. VP Finance/CFO
Holdings: 133,990 shares
Latest Transaction: Jul 06 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ADAM C DERBYSHIRE in SALIX PHARMACEUTICALS LTD
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 98,000 | |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 99,000 | |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.76 | 1,000 | 12,760 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.99 | 1,000 | 12,990 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.55 | 1,000 | 12,550 | 108,371 | 109.4 K to 108.4 K (-0.91 %) |
Jul 29 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 100,000 | |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 101,000 | |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 102,000 | |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.17 | 100 | 1,217 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.19 | 200 | 2,438 | 108,471 | 108.7 K to 108.5 K (-0.18 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.22 | 100 | 1,222 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.29 | 25 | 307 | 108,771 | 108.8 K to 108.8 K (-0.02 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.38 | 175 | 2,167 | 108,796 | 109 K to 108.8 K (-0.16 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 12.41 | 400 | 4,964 | 108,971 | 109.4 K to 109 K (-0.37 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.75 | 100 | 1,175 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.76 | 300 | 3,528 | 108,471 | 108.8 K to 108.5 K (-0.28 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.78 | 200 | 2,356 | 108,771 | 109 K to 108.8 K (-0.18 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.80 | 100 | 1,180 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.81 | 100 | 1,181 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.82 | 200 | 2,364 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.31 | 270 | 3,054 | 108,371 | 108.6 K to 108.4 K (-0.25 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.34 | 30 | 340 | 108,641 | 108.7 K to 108.6 K (-0.03 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.35 | 100 | 1,135 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.37 | 300 | 3,411 | 108,771 | 109.1 K to 108.8 K (-0.28 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.38 | 200 | 2,276 | 109,071 | 109.3 K to 109.1 K (-0.18 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.41 | 100 | 1,141 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 24 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 103,000 | |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 104,000 | |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 105,000 | |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.00 | 175 | 1,925 | 108,371 | 108.5 K to 108.4 K (-0.16 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.02 | 25 | 276 | 108,546 | 108.6 K to 108.5 K (-0.02 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.03 | 200 | 2,206 | 108,571 | 108.8 K to 108.6 K (-0.18 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.04 | 300 | 3,312 | 108,771 | 109.1 K to 108.8 K (-0.28 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.05 | 200 | 2,210 | 109,071 | 109.3 K to 109.1 K (-0.18 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.06 | 100 | 1,106 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.97 | 100 | 1,097 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.01 | 100 | 1,101 | 108,471 | 108.6 K to 108.5 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.02 | 400 | 4,408 | 108,571 | 109 K to 108.6 K (-0.37 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.03 | 300 | 3,309 | 108,971 | 109.3 K to 109 K (-0.27 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.06 | 100 | 1,106 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.68 | 300 | 3,204 | 108,371 | 108.7 K to 108.4 K (-0.28 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.70 | 100 | 1,070 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.81 | 300 | 3,243 | 108,771 | 109.1 K to 108.8 K (-0.28 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.83 | 100 | 1,083 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.86 | 100 | 1,086 | 109,171 | 109.3 K to 109.2 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.87 | 100 | 1,087 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 21 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 106,000 | |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 107,000 | |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 108,000 | |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.85 | 100 | 1,085 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.88 | 100 | 1,088 | 108,471 | 108.6 K to 108.5 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.94 | 100 | 1,094 | 108,571 | 108.7 K to 108.6 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.95 | 100 | 1,095 | 108,671 | 108.8 K to 108.7 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.96 | 100 | 1,096 | 108,771 | 108.9 K to 108.8 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.97 | 100 | 1,097 | 108,871 | 109 K to 108.9 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.98 | 200 | 2,196 | 108,971 | 109.2 K to 109 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 11.00 | 200 | 2,200 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.43 | 283 | 2,952 | 108,371 | 108.7 K to 108.4 K (-0.26 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.48 | 317 | 3,322 | 108,654 | 109 K to 108.7 K (-0.29 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.52 | 200 | 2,104 | 108,971 | 109.2 K to 109 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.63 | 200 | 2,126 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.55 | 200 | 2,110 | 108,371 | 108.6 K to 108.4 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.56 | 100 | 1,056 | 108,571 | 108.7 K to 108.6 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.57 | 200 | 2,114 | 108,671 | 108.9 K to 108.7 K (-0.18 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.59 | 100 | 1,059 | 108,871 | 109 K to 108.9 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.61 | 100 | 1,061 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.62 | 100 | 1,062 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.64 | 100 | 1,064 | 109,171 | 109.3 K to 109.2 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.66 | 100 | 1,066 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 16 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 109,000 | |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 110,000 | |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 111,000 | |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.97 | 300 | 2,991 | 108,371 | 108.7 K to 108.4 K (-0.28 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.98 | 500 | 4,990 | 108,671 | 109.2 K to 108.7 K (-0.46 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.05 | 100 | 1,005 | 109,171 | 109.3 K to 109.2 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.06 | 100 | 1,006 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.68 | 249 | 2,410 | 108,371 | 108.6 K to 108.4 K (-0.23 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.69 | 100 | 969 | 108,620 | 108.7 K to 108.6 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.70 | 51 | 495 | 108,720 | 108.8 K to 108.7 K (-0.05 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.71 | 173 | 1,680 | 108,771 | 108.9 K to 108.8 K (-0.16 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.73 | 100 | 973 | 108,944 | 109 K to 108.9 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.75 | 100 | 975 | 109,044 | 109.1 K to 109 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 100 | 976 | 109,144 | 109.2 K to 109.1 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 100 | 978 | 109,244 | 109.3 K to 109.2 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.79 | 2 | 20 | 109,344 | 109.3 K to 109.3 K (0.00 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.81 | 25 | 245 | 109,346 | 109.4 K to 109.3 K (-0.02 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.86 | 100 | 986 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.90 | 500 | 4,950 | 108,471 | 109 K to 108.5 K (-0.46 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.93 | 100 | 993 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.95 | 300 | 2,985 | 109,071 | 109.4 K to 109.1 K (-0.27 %) |
Jul 13 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 112,000 | |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 113,000 | |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 114,000 | |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 200 | 1,952 | 108,371 | 108.6 K to 108.4 K (-0.18 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.79 | 500 | 4,895 | 108,571 | 109.1 K to 108.6 K (-0.46 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.83 | 103 | 1,012 | 109,071 | 109.2 K to 109.1 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.84 | 97 | 954 | 109,174 | 109.3 K to 109.2 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.85 | 100 | 985 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.83 | 100 | 983 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.84 | 400 | 3,936 | 108,471 | 108.9 K to 108.5 K (-0.37 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.86 | 400 | 3,944 | 108,871 | 109.3 K to 108.9 K (-0.37 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.87 | 100 | 987 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 100 | 976 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.77 | 600 | 5,862 | 108,471 | 109.1 K to 108.5 K (-0.55 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 300 | 2,934 | 109,071 | 109.4 K to 109.1 K (-0.27 %) |
Jul 08 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 115,000 | |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 116,000 | |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.37 | 100 | 937 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.39 | 200 | 1,878 | 108,471 | 108.7 K to 108.5 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.47 | 200 | 1,894 | 108,671 | 108.9 K to 108.7 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.48 | 100 | 948 | 108,871 | 109 K to 108.9 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.55 | 200 | 1,910 | 108,971 | 109.2 K to 109 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.57 | 200 | 1,914 | 109,171 | 109.4 K to 109.2 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.71 | 100 | 971 | 108,371 | 108.5 K to 108.4 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.73 | 300 | 2,919 | 108,471 | 108.8 K to 108.5 K (-0.28 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.76 | 200 | 1,952 | 108,771 | 109 K to 108.8 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.78 | 100 | 978 | 108,971 | 109.1 K to 109 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.80 | 200 | 1,960 | 109,071 | 109.3 K to 109.1 K (-0.18 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.81 | 100 | 981 | 109,271 | 109.4 K to 109.3 K (-0.09 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 109,371 | 108.4 K to 109.4 K (+0.92 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 0.00 | 31,010 | 0 | 108,371 | 77.4 K to 108.4 K (+40.08 %) |
Jul 06 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 9.87 | 6,028 | 59,496 | 77,361 | 83.4 K to 77.4 K (-7.23 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 1.13 | 1,000 | 1,133 | 117,000 | |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.98 | 100 | 998 | 83,389 | 83.5 K to 83.4 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 9.99 | 101 | 1,009 | 83,489 | 83.6 K to 83.5 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.00 | 200 | 2,000 | 83,590 | 83.8 K to 83.6 K (-0.24 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.01 | 99 | 991 | 83,790 | 83.9 K to 83.8 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.03 | 300 | 3,009 | 83,889 | 84.2 K to 83.9 K (-0.36 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.04 | 100 | 1,004 | 84,189 | 84.3 K to 84.2 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 10.08 | 100 | 1,008 | 84,289 | 84.4 K to 84.3 K (-0.12 %) |
Jul 02 2009 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 1.13 | 1,000 | 1,133 | 84,389 | 83.4 K to 84.4 K (+1.20 %) |